Fuso Pharmaceutical Industries (TSE:4538) Accounts Payable & Accrued Expense : 円8,251 Mil (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Fuso Pharmaceutical Industries Accounts Payable & Accrued Expense?

Fuso Pharmaceutical Industries's quarterly accounts payable & accrued expense increased from Jun. 2023 (円7,027 Mil) to Sep. 2023 (円7,824 Mil) and increased from Sep. 2023 (円7,824 Mil) to Dec. 2023 (円8,251 Mil).

Fuso Pharmaceutical Industries's annual accounts payable & accrued expense declined from Mar. 2021 (円9,315 Mil) to Mar. 2022 (円7,365 Mil) but then increased from Mar. 2022 (円7,365 Mil) to Mar. 2023 (円7,461 Mil).

Fuso Pharmaceutical Industries Accounts Payable & Accrued Expense Historical Data

The historical data trend for Fuso Pharmaceutical Industries's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuso Pharmaceutical Industries Accounts Payable & Accrued Expense Chart

Fuso Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11,636.00

11,136.00

9,315.00

7,365.00

7,461.00

Fuso Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7,122.00	7,461.00	7,027.00	7,824.00	8,251.00

Fuso Pharmaceutical Industries Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Fuso Pharmaceutical Industries (TSE:4538) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuso Pharmaceutical Industries Ltd (TSE:4538) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045

Website

http://www.fuso-pharm.co.jp

Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid.

Fuso Pharmaceutical Industries (TSE:4538) Headlines

No Headlines